Over 90 per cent of the subjects in the phase 1 trials developed an immune response to HIV. The study was conducted by researchers at Karolinska Institutet (KI), Karolinska University Hospital and the Swedish Institute for Infectious Disease Control (SMI).
Read more about the results from Swedish study of HIV vaccine at the Karolinska Institutet web site.
Your Comments, Thoughts, Questions, Ideas
Explore
Recent comments
What is the purpose of museums? To educate the next generation. How are we to be educated when...
We saw a completely white squirrel today on our walk to the end of our street and back. We live in...
I never used to have a fear of heights, either, like a lot of you, but I do now on some things. I'...
I just had steroid injections in my knees about 36 hours ago. I started hiccuping about 4 hours ago...
Subscribe
Connect with Science Buzz on Facebook and Twitter.
You can also subscribe to our RSS feed using any newsreader software.
Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Hurwitz BE, et al.
"CONCLUSIONS: Daily selenium supplementation can suppress the progression of HIV-1 viral burden and provide indirect improvement of CD4 count. The results support the use of selenium as a simple, inexpensive, and safe adjunct therapy in HIV spectrum disease." And this was only with 200 mcg of selenium, where it is safe to take 800 mcg per day.
This HIV vaccine trial did not use selenium supplementation.
Hope the HIV vaccine is helpful to me. I read this news on pozcupid.com before. Seems many people are interested.
Post new comment